Reflexion Pharmaceuticals, Inc.

SAN FRANCISCO, CA · Founded 2008 · CIK 0001534808 · Medtech · Private

Radiotherapy delivery system using live, continuously updated imaging data to guide real-time dose targeting to tumors

reflexion.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.1M
1 Form D · Dec 2011
178 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,143,926
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1074Paradromics, Inc.—$55M
1075ResQ Pharma, Inc.—$2.4M
1076ZSX MEDICAL LLC—$1.1M
1077Reflexion Pharmaceuticals, Inc.—$1.1M
1078PathogenDx, Inc.—$675K
1079DANAHER CORP /DE/—$13M
1080Vira Regen Inc.—$3.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 15 related persons
  • Dana Ault-Riche'Director · Executive Officer · Promoter
  • Hans-Peter BiemannPromoter
  • Heng ChangPromoter
  • Peter CrowleyPromoter
  • Patrick DentingerPromoter
  • Douglas FlorenPromoter
  • Ismael HidalgoPromoter
  • John KenneyPromoter
  • Stephen KentDirector · Promoter
  • Gurdev SidhuPromoter
  • Sachdev SidhuDirector · Promoter
  • Joseph SilettoPromoter
  • Dario SlavazzaPromoter
  • Albertus van den BroekPromoter
  • Richard van den BroekPromoter

Patents

USPTO · 0 granted of 3
  • Multivalent D-peptidic Compounds For Target Proteinsapplication
  • D-peptidic Vegf-a Binding Compounds And Methods For Using The Sameapplication
  • Multivalent D-peptidic Compounds For Target Proteinsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.